MiRus announced new early feasibility study results supporting the use of its Siegel transcatheter aortic valve replacement ...

Transcatheter aortic valve implantation (TAVI) is now an established treatment option for elderly patients with severe ...

A true test of durability will take many more years, but if the valve holds up, it’s “potentially a game changer,” say ...

Permanent pacemaker rates were nearly 18% at 30 days but came down as sites gained experience with the new device.